MolecuLight, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

MolecuLight, Inc.
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name MolecuLight, Inc.. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Nov 5, 2026 to Nov 5, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code MUD appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 425 University Ave., Suite 700, Suite 700, Toronto, M5G 1, CA. Recorded on K262858, decision dated Nov 5, 2026.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Devices & associated records
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
OxySight for MolecuLightDX+K262858 | MolecuLight, Inc. | 510(k) clearance | Nov 5, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 19, 2026.
